ID

28043

Beschreibung

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Past medical conditions

Stichworte

Versionen (3)

1. 27.08.17 27.08.17 -
2. 23.10.17 23.10.17 -
3. 12.12.17 12.12.17 -

Rechteinhaber

GlaxoSmithKline

Hochgeladen am

12. Dezember 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz